ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Congress Approves FY 2010 Budget. Loehrer Named Interim Director At Indiana

April 10, 2009

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980